QuantuMDx and SCIENION Partner to Commercialise Novel Nanowire Biosensor
Read moreNewcastle-Upon-Tyne, England and Berlin, Germany, June 9, 2015: British medical device developer QuantuMDx (QMDx) and German life sciences company SCIENION have partnered to take QMDx’s highly multiplexed nanowire array to market. This biosensor is a component of QMDx’s flagship product Q-POC™, a handheld molecular diagnostic device that will provide results in 15 minutes for a few pounds at the patient’s side.